first glp 1 drug glp-1 GLP-1s for Weight Loss: What You Need to Know FDA Approves First ORAL GLP-1
Description
Practical Guidance on Allulose and GLP-1 Medications For individuals considering allulose as part of their dietary strategy, particularly those taking GLP-1 receptor agonist medications, several practical considerations can help ensure safe and effective use

Use of DPP4 inhibitors and GLP-1 receptor agonists and risk of intestinal obstruction: scandinavian cohort study

Risk of cardiovascular outcomes in patients with type 2 diabetes after addition of SGLT2 inhibitors versus sulfonylureas to baseline GLP-1RA therapy
Diabetes is the most common single cause of gastroparesis
There is no evidence to support any one type of diet composition over another for anthropometric, metabolic, hormonal, reproductive, or psychological outcomes

The only difference is that Bydureon is long-lasting, requiring only one injection per week, whereas Byetta is taken twice-daily due to its much shorter-term effects
